For: | Pham TN, Michalak TI. Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol 2008; 14(18): 2789-2793 [PMID: 18473399 DOI: 10.3748/wjg.14.2789] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i18/2789.htm |
Number | Citing Articles |
1 |
Cecilia Fernandez-Ponce, Margarita Dominguez-Villar, Enrique Aguado, Francisco Garcia-Cozar, Derya Unutmaz. CD4+ Primary T Cells Expressing HCV-Core Protein Upregulate Foxp3 and IL-10, Suppressing CD4 and CD8 T Cells. PLoS ONE 2014; 9(1): e85191 doi: 10.1371/journal.pone.0085191
|
2 |
Yasuteru Kondo, Yoshiyuki Ueno, Tooru Shimosegawa. Biological Significance of HCV in Various Kinds of Lymphoid Cells. International Journal of Microbiology 2012; 2012: 1 doi: 10.1155/2012/647581
|
3 |
M. Sidorkiewicz, M. Brocka, M. Bronis, M. Grek, B. Jozwiak, A. Piekarska, J. Bartkowiak. The altered expression of α1 and β3 subunits of the gamma-aminobutyric acid A receptor is related to the hepatitis C virus infection. European Journal of Clinical Microbiology & Infectious Diseases 2012; 31(7): 1537 doi: 10.1007/s10096-011-1475-8
|
4 |
Kei Fujiwara, Robert D. Allison, Richard Y. Wang, Patricia Bare, Kentaro Matsuura, Cathy Schechterly, Krishna Murthy, Francesco M. Marincola, Harvey J. Alter. Investigation of Residual Hepatitis C Virus in Presumed Recovered Subjects. Hepatology 2013; 57(2): 483 doi: 10.1002/hep.25921
|
5 |
Luca Mercuri, Emma C. Thomson, Joseph Hughes, Peter Karayiannis. Quasispecies Changes with Distinctive Point Mutations in the Hepatitis C Virus Internal Ribosome Entry Site (IRES) Derived from PBMCs and Plasma. Advances in Virology 2018; 2018: 1 doi: 10.1155/2018/4835252
|
6 |
M. C. Roque-Cuéllar, B. Sánchez, J. R. García-Lozano, J. M. Praena-Fernández, A. Núñez-Roldán, J. Aguilar-Reina. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients. Journal of Viral Hepatitis 2011; 18(10): e541 doi: 10.1111/j.1365-2893.2011.01464.x
|
7 |
Tram N. Q. Pham, Carla S. Coffin, Tomasz I. Michalak. Occult hepatitis C virus infection: what does it mean?. Liver International 2010; 30(4): 502 doi: 10.1111/j.1478-3231.2009.02193.x
|
8 |
Zania Stamataki. Hepatitis C infection of B lymphocytes: more tools to address pending questions. Expert Review of Anti-infective Therapy 2010; 8(9): 977 doi: 10.1586/eri.10.86
|
9 |
Yaron Rotman, T. Jake Liang. Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes. Journal of Virology 2009; 83(15): 7366 doi: 10.1128/JVI.00191-09
|
10 |
M. Dominguez‐Villar, F. J. Garcia‐Cozar, B. J. Chambers. The Effects of Hepatitis C Virus Core Protein on Functional Responses in the NK Cell Line YTS. Scandinavian Journal of Immunology 2012; 75(1): 54 doi: 10.1111/j.1365-3083.2011.02624.x
|
11 |
Amira A. Shahin, Soha M. El Desouky, Hania S. Zayed. A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide. Clinical Rheumatology 2011; 30(5): 607 doi: 10.1007/s10067-010-1582-4
|
12 |
Konstantina Katsarou, Elisavet Serti, Panagiota Tsitoura, Alexandros A. Lavdas, Agoritsa Varaklioti, Angela-Maria Pickl-Herk, Dieter Blaas, Devrim Oz-Arslan, Rong Zhu, Peter Hinterdorfer, Penelope Mavromara, Urania Georgopoulou. Green fluorescent protein – Tagged HCV non-enveloped capsid like particles: Development of a new tool for tracking HCV core uptake. Biochimie 2009; 91(7): 903 doi: 10.1016/j.biochi.2009.04.016
|
13 |
Masahiko Ito, Hideki Kusunoki, Keiko Mochida, Kazunari Yamaguchi, Toshiaki Mizuochi. HCV Infection and B-Cell Lymphomagenesis. Advances in Hematology 2011; 2011: 1 doi: 10.1155/2011/835314
|
14 |
Paolo Conca, Giovanni Tarantino. Hepatitis C virus lymphotropism and peculiar immunological phenotype: Effects on natural history and antiviral therapy. World Journal of Gastroenterology 2009; 15(19): 2305-2308 doi: 10.3748/wjg.15.2305
|
15 |
Sibnarayan Datta, Soumya Chatterjee, Rudragoud S Policegoudra, Hemant K Gogoi, Lokendra Singh. Hepatitis viruses and non-Hodgkin’s lymphoma: A review. World Journal of Virology 2012; 1(6): 162-173 doi: 10.5501/wjv.v1.i6.162
|
16 |
Sibnarayan Datta, Rajesh Panigrahi, Avik Biswas, Partha K. Chandra, Arup Banerjee, Pradip K. Mahapatra, Chinmoy K. Panda, Shekhar Chakrabarti, Sujit K. Bhattacharya, Kuntal Biswas, Runu Chakravarty. Genetic Characterization of Hepatitis B Virus in Peripheral Blood Leukocytes: Evidence for Selection and Compartmentalization of Viral Variants with the Immune Escape G145R Mutation. Journal of Virology 2009; 83(19): 9983 doi: 10.1128/JVI.01905-08
|
17 |
Hossein Keyvani, Farah Bokharaei-Salim, Seyed Hamidreza Monavari, Maryam Esghaei, Mohssen Nassiri Toosi, Shahin Fakhim, Zohreh-Azita Sagigh, Seyed Moayed Alavian. Occult Hepatitis C Virus Infection in Candidates for Liver Transplant With Cryptogenic Cirrhosis. Hepatitis Monthly 2013; 13(8) doi: 10.5812/hepatmon.11290
|
18 |
Florian Douam, Louis-Marie Bobay, Guillemette Maurin, Judith Fresquet, Noémie Calland, Carine Maisse, Tony Durand, François-Loïc Cosset, Cyrille Féray, Dimitri Lavillette, M. S. Diamond. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients. Journal of Virology 2016; 90(2): 992 doi: 10.1128/JVI.02516-15
|
19 |
Bernadien M Nijmeijer, Jelle Koopsen, Janke Schinkel, Maria Prins, Teunis BH Geijtenbeek. Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men. Journal of the International AIDS Society 2019; 22(S6) doi: 10.1002/jia2.25348
|
20 |
Giuseppe Sautto, Nicasio Mancini, Laura Solforosi, Roberta A. Diotti, Massimo Clementi, Roberto Burioni. HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role. Clinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/705013
|
21 |
María C. Roque‐Cuéllar, Berta Sánchez, José R. García‐Lozano, Juan M. Praena‐Fernández, José L. Márquez‐Galán, Antonio Núñez‐Roldán, José Aguilar‐Reina. Hepatitis C virus‐specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells. Liver International 2014; 34(6) doi: 10.1111/liv.12320
|
22 |
Céline Miroux, Thibaut Vausselin, Nadira Delhem. Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response. Expert Opinion on Biological Therapy 2010; 10(11): 1563 doi: 10.1517/14712598.2010.529125
|
23 |
Giuseppe Sautto, Nicasio Mancini, Massimo Clementi, Roberto Burioni. Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII). Viruses 2012; 4(11): 2924 doi: 10.3390/v4112924
|
24 |
Richard Y. Wang, Patricia Bare, Valeria De Giorgi, Kentaro Matsuura, Kazi Abdus Salam, Teresa Grandinetti, Cathy Schechterly, Harvey J. Alter. Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system. Hepatology 2016; 64(6): 1900 doi: 10.1002/hep.28842
|
25 |
Leonard B. Seeff. Sustained Virologic Response: Is This Equivalent to Cure of Chronic Hepatitis C?. Hepatology 2013; 57(2): 438 doi: 10.1002/hep.25964
|
26 |
Nassim Kamar, Florence Nicot, Jacques Izopet, Lionel Rostaing. Occult Hepatitis C Virus Infection in Hemodialysis Patients: Examining the Evidence. American Journal of Kidney Diseases 2009; 54(1): 10 doi: 10.1053/j.ajkd.2008.12.033
|
27 |
T. N. Q. Pham, S. E. Mercer, T. I. Michalak. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. Journal of Viral Hepatitis 2009; 16(8): 547 doi: 10.1111/j.1365-2893.2009.01092.x
|
28 |
|